Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis

Journal of Clinical Investigation

Volumn 105, Issue 8, 2000, Pages 1109-1116

  Issazadeh, Shohreh ^a,e   Abdallah, Kald ^b   Chitnis, Tanuja ^a   Chandraker, Anil ^b   Wells, Andrew D ^c   Turka, Laurence A ^c   Sayegh, Mohamed H ^b   Khoury, Samia J ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Center for Neurologic Diseases   (United States)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034005892     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8607     Document Type: Article

References (26)

1. Van Parijs, L., and Abbas, A.K. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243-248.
2. Schmied, M., et al. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:446-452.
3. Grillot, D.A., Merino, R., and Nunez, G. 1995. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973-1983.
4. Boise, L.H., et al. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoprotic cell death. Cell. 74:597-608.
5. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., and Korsmeyer, S.J. 1990. Bcl-2 is an inner mitochondrial membrane prorein that blocks programmed cell death. Nature. 348:334-336.
6. Nuinez, G, Merino, R., Grillot, IX, and Gonzales-Garcia, M. 1994. Bcl-2 and Bcl-x: regulatory switches tor lymphoid death and survival. Immunol. Today. 15:582-588.
7. Schwartz, R.H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1065-1068.
8. Van Parijs, L., Peterson, D.A., and Abbas, A.K. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity. 8:265-274.
9. Van Parijs, L., Biuckians, A., and Abbas, A.K. 1998. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 160:2065-2071.
10. Lenardo, M. 1991. Interleukin-2 programs mouse αβT lymphocytes for apoptosis. Nature. 353:858-861.
11. Sabelko, K.A., Kelly, K.A., Nahm, M.H., Cross, A.H., and Russell, J.H. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, bur are not essential for immune privilege in the central nervous system. J. Immunol. 159:3096-3099.
12. Waldner, H., Sobel, R.A., Howard, E., and Kuchroo, V.K. 1997. Fas-and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100-3103.
13. Suvannavejh, G.C. Dal Canto, M.C., Matis, L.A., and Miller, S.D. 2000. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105:223-231.
14. Boise, L.H., et al. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bel-XL Immunity. 3:87-98.
15. Noel, P.J., Boise, L.H., Green, J.M., and Thompson, C.B. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636-642.
16. Sperling, A.I., et al. 1996. CD28/B7 interactions deliver a unique signal ro naive T ceils that regulates cell survival but not early proliferation. J. Immunol. 157:3909-3917.
17. Wells, A.D., et al. 1999. Requirement for T-cell apoprosis in the induction of peripheral transplantation tolerance. Nat. Med. 5:1303-1307.
18. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M.H., and Khoury, S.J. 1998. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161:1104-1112.
19. Issazadeh, S., Zhang, M., Sayegh, M.H., and Khoury, S.J. 1999. Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. J. Immunol. 162:761-765.
20. Slavin, A., et al. 1998. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. 28:109-120.
21. I. Deibler, G.E., Martenson, R.E., and Kies, M.W. 1972. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:139-165.
22. Schmid, I., Uittenbogaart, C.H., Keld, B., and Giorgi, J.V. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol Methods. 170:145-157.
23. Tabi, Z., McCombe, P.A., and Pender, M.P. 1995. Antigen-specific downregulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int. Immunol. 7:967-973.
24. White, C.A., McCombe, P.A., and Pender, M.P. 1998. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental an to immune encephalomyelitis, J. Neuroimmunol. 82:47-55.
25. Chen, Y., Hancock, W.W., Marks, R., Gonnella, P., and Weiner, H.L. 1998. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice. J. Neuroimmunol. 82:149-159.
26. Bonetti, B., Pohl, J., Gao, Y.L., and Raine, C.S. 1997. Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:5733-5741.